Publications by authors named "Maeve A Lowery"

Claim this Profile
F
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial.
Maeve A Lowery, Lucjan S Wyrwicz, Do-Youn Oh, Kai-Keen Shiu, Patricio Yañez

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to PARPi in Pancreatic Ductal Adenocarcinoma.
Jojanneke Stoof, Charlotte Andrieu, Fiona O'Connell, Jacintha O'Sullivan, Maeve A Lowery

J Cell Mol Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170].
Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, Julien Edeline, Mairéad G McNamara, Maeve A Lowery

Lancet Reg Health Eur· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Fibrolamellar Cancer Registry: Opportunities and Challenges.
Layal Al Mahmasani, Marinela Capanu, Kurt Losert, Joanne F Chou, Maeve Aine Lowery

JCO Glob Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe.
Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, Julien Edeline, Mairéad G McNamara, Maeve A Lowery

Lancet Reg Health Eur· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-checkpoint blockade in surgical management of gastric or gastro-oesophageal junction adenocarcinoma.
Maeve A Lowery

Lancet Gastroenterol Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifiable risk factors for cancer among people with lynch syndrome: an international, cross-sectional survey.
Robert F Power, Damien E Doherty, Roberta Horgan, Pat Fahey, David J Gallagher, Maeve A Lowery

Hered Cancer Clin Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Kjetil Taskén, Soemeya F Haj Mohammad, Gro Live Fagereng, Ragnhild Sørum Falk, Åslaug Helland, Maeve A Lowery

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifiable Risk Factors and Risk of Colorectal and Endometrial Cancers in Lynch Syndrome: A Systematic Review and Meta-Analysis.
Robert F Power, Damien E Doherty, Imelda Parker, David J Gallagher, Maeve A Lowery

JCO Precis Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
John V Reynolds, Shaun R Preston, Brian O'Neill, Maeve A Lowery, Lene Baeksgaard

Lancet Gastroenterol Hepatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Sun Young Rha, Do-Youn Oh, Patricio Yañez, Yuxian Bai, Min-Hee Ryu, Maeve A Lowery

Lancet Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient knowledge, personal experience, and impact of the first wave of the COVD-19 pandemic in an Irish oncology cohort.
Ruth Kieran, Carolyn Moloney, Scheryll Alken, Lynda Corrigan, David Gallagher, Maeve A Lowery

Ir J Med Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving the Needle on Precision Medicine in Pancreatic Cancer.
Grainne M O'Kane, Maeve A Lowery

J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangiocarcinoma Harboring FGFR2 Alterations.
Anna M Varghese, Juber Patel, Yelena Y Janjigian, Fanli Meng, S Duygu Selcuklu, Maeve A Lowery

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
Andrew X Zhu, Teresa Macarulla, Milind M Javle, R Kate Kelley, Sam J Lubner, Maeve A Lowery

JAMA Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives.
Jojanneke Stoof, Emily Harrold, Sarah Mariottino, Maeve A Lowery, Naomi Walsh

Front Cell Dev Biol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes.
Anna M Varghese, Isha Singh, Rituraj Singh, Siddharth Kunte, Joanne F Chou, Maeve A Lowery

J Natl Cancer Inst· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
Thomas Boerner, Esther Drill, Linda M Pak, Bastien Nguyen, Carlie S Sigel, Maeve A Lowery

Hepatology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and morphological changes induced by ivosidenib correlate with efficacy in mutant- cholangiocarcinoma.
Elia Aguado-Fraile, Ania Tassinari, Yuko Ishii, Carlie Sigel, Maeve A Lowery

Future Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants.
Robert Power, Cristin Leavy, Carmel Nolan, Niamh White, Roisin Clarke, Maeve Aine Lowery

Fam Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Ghassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, Robin K Kelley, Sam J Lubner, Maeve A Lowery

Lancet Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cancer-Immune Set Point in Oesophageal Cancer.
Robert Power, Maeve A Lowery, John V Reynolds, Margaret R Dunne

Front Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline Mutation.
Eileen M O'Reilly, Jonathan W Lee, Mark Zalupski, Marinela Capanu, Jennifer Park, Maeve A Lowery

J Clin Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-phenotype correlation in BRCA1/2 mutation-associated pancreatic cancer.
Maeve A Lowery

Br J Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.
Hannah Maynard, Zsofia K Stadler, Michael F Berger, David B Solit, Michele Ly, Maeve A Lowery

Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis